Author

Nicola Bell

Royal Marsden NHS Foundation TrustPrimary ORCID profile (0000-0002-2137-4250 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nicola BelliD1 paper · The University of Queensland

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Alice GarrettiD· 1 shared Angela Joy GeorgeiD· 1 shared Bethany TorriD· 1 shared Caitlin T. FierhelleriD· 1 shared Clare TurnbulliD· 1 shared D. Gareth EvansiD· 1 shared Helena HarderiD· 1 shared Joshua J. NolaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Alice GarrettORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathway

Bethany Torr, Lea Mansour, Caitlin T. Fierheller, Monica Hamill, Joshua J. Nolan, Nicola Bell, Subin Choi, Sophie Allen, Sudeekshna Muralidharan, Suzanne MacMahon, Yasmin Clinch, Mikel Valgañón, Helena Harder, Alice Garrett, D. Gareth Evans, , Clare Turnbull

This paper evaluates a streamlined germline genetic testing pathway for breast cancer patients, showing high satisfaction and feasibility while highlighting the need for simplified criteria to improve detection of pathogenic variants.

npj Breast Cancer · Jul 9, 2026Peer-reviewedGenetic & Genomic Medicine